0001209191-18-053535.txt : 20181002
0001209191-18-053535.hdr.sgml : 20181002
20181002213800
ACCESSION NUMBER: 0001209191-18-053535
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180928
FILED AS OF DATE: 20181002
DATE AS OF CHANGE: 20181002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Frazier Life Sciences VIII, L.P.
CENTRAL INDEX KEY: 0001655827
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38670
FILM NUMBER: 181103605
BUSINESS ADDRESS:
STREET 1: 601 UNION STREET
STREET 2: SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
BUSINESS PHONE: 206-254-7200
MAIL ADDRESS:
STREET 1: 601 UNION STREET
STREET 2: SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FHM LIFE SCIENCES VIII, L.L.C.
CENTRAL INDEX KEY: 0001698823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38670
FILM NUMBER: 181103606
BUSINESS ADDRESS:
STREET 1: 601 UNION STREET
STREET 2: SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
BUSINESS PHONE: 206.621.7200
MAIL ADDRESS:
STREET 1: 601 UNION STREET
STREET 2: SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heron Patrick J
CENTRAL INDEX KEY: 0001365617
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38670
FILM NUMBER: 181103607
MAIL ADDRESS:
STREET 1: 550 HAMILTON AVE., SUITE 100
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FHM LIFE SCIENCES VIII, L.P.
CENTRAL INDEX KEY: 0001698755
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38670
FILM NUMBER: 181103608
BUSINESS ADDRESS:
STREET 1: 601 UNION STREET
STREET 2: SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
BUSINESS PHONE: 206.621.7200
MAIL ADDRESS:
STREET 1: 601 UNION STREET
STREET 2: SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Entasis Therapeutics Holdings Inc.
CENTRAL INDEX KEY: 0001724344
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824592913
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 810-0120
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Entasis Therapeutics Ltd
DATE OF NAME CHANGE: 20171204
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-09-28
0
0001724344
Entasis Therapeutics Holdings Inc.
ETTX
0001655827
Frazier Life Sciences VIII, L.P.
601 UNION STREET, SUITE 3200
SEATTLE
WA
98101
0
0
1
0
0001698823
FHM LIFE SCIENCES VIII, L.L.C.
601 UNION STREET, SUITE 3200
SEATTLE
WA
98101
0
0
1
0
0001365617
Heron Patrick J
601 UNION STREET, SUITE 3200
SEATTLE
WA
98101
0
0
1
0
0001698755
FHM LIFE SCIENCES VIII, L.P.
601 UNION STREET, SUITE 3200
SEATTLE
WA
98101
0
0
1
0
Common Stock
2018-09-28
4
C
0
337707
A
337707
D
Common Stock
2018-09-28
4
C
0
251487
A
589194
D
Common Stock
2018-09-28
4
C
0
320898
A
974066
D
Common Stock
2018-09-28
4
P
0
375887
15.00
A
1349953
D
Series B Convertible Preferred Stock
2018-09-28
4
C
0
7000000
0.00
D
Common Stock
337707
0
D
Series B-1 Tranche A Convertible Preferred Stock
2018-09-28
4
C
0
5212833
0.00
D
Common Stock
251487
0
D
Series B-1 Tranche B Convertible Preferred Stock
2018-09-28
4
C
0
6651574
0.00
D
Common Stock
320898
0
D
Each share of Series B Preferred Stock, Series B-1 Tranche A Convertible Preferred Stock and Series B-1 Tranche B Convertible Preferred Stock (collectively, the "Preferred Stock") automatically converted into Common Stock on a 20.728-for-one basis upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
The reportable securities are held directly by Frazier Life Sciences VIII, L.P. ("FLS LP"). FHM Life Sciences VIII, L.P. ("FHM LP") is the general partner of FLS LP. FHM Life Sciences VIII, L.L.C. ("FHM LLC") is the general partner of FHM LP. James Topper and Patrick Heron are the sole managing members of FHM LLC. Mr. Heron, FHM LP and FHM LLC disclaims beneficial ownership of the securities held by FLS LP except, to the extent of his or its pecuniary interest therein, if any.
This number includes an aggregate of 63,974 shares of Common Stock received upon the conversion of the Issuer's Preferred Stock as payment of the accrued dividends through September 27, 2018. No dividends will accrue after September 27, 2018.
Frazier Life Sciences VIII, L.P. By: FHM Life Sciences VIII, L.P. Its: general partner By FHM Life Sciences VIII, L.L.C. Its: general partner, By: /s/ Steve Bailey
2018-10-02
FHM Life Sciences VIII, L.L.C. By: /s/ Steve Bailey
2018-10-02
/s/ Steve Bailey, Attorney-in-Fact for Patrick J. Heron
2018-10-02
FHM Life Sciences VIII, L.P. By: FHM Life Sciences VIII, L.L.C. Its: general partner By: /s/ Steve Bailey
2018-10-02